These insights represent the first characterization of risk factors for respiratory failure–related hospitalization among patients with sarcoidosis‐associated pulmonary hypertension (SAPH). Newly ...

The identification of poor prognostic features in patients with PAH should prompt a timely referral for assessment for lung transplantation. A major component of the transplant assessment process is ...

Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research. It's hard to avoid the pitch for Viagra on the television commercials and e-mail spam. Directed at the ...

Please provide your email address to receive an email when new articles are posted on . An inhaled formulation of the PDE5 inhibitor vardenafil, in development for as-needed use for episodic symptoms ...

PAH is a disorder of vasoconstriction and proliferation, and treatment focuses on medications that act on or reverse these specific events. Conventional therapy consists of diuretics, oxygen, ...

German researchers have demonstrated that oral sildenafil, a potent acute pulmonary vasodilator that widens blood vessels, could be a new treatment agent for chronic thromboembolic pulmonary ...

Dr. Alison S. Witkin: A 21-year-old male college student was evaluated in the cardiology clinic at this hospital, before the coronavirus disease 2019 pandemic, because of progressive dyspnea. When the ...

The FDA has accepted for review the New Drug Application for Trevyent (treprostinil), a drug-device combination product for the treatment of pulmonary arterial hypertension The Food and Drug ...

A new pilot study from the Icahn School of Medicine at Mount Sinai suggests that COVID-19 is causing significant dilation of the blood vessels of the lung, specifically the capillaries. This ...